Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

KEYNOTE-564: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy...

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

KEYNOTE-564: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

RELATIVITY-047: Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first...

Dr Evan Jacob Lipson - Johns Hopkins Sidney Kimmel Comprehensive Cancer Center...

RELATIVITY-047: Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma ( Dr Evan Jacob Lipson - Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )

European Cancer Organisation - Time to Act

Dr Mirjam Crul - Amsterdam University Medical Center, Amsterdam, Netherlands

European Cancer Organisation - Time to Act ( Dr Mirjam Crul - Amsterdam University Medical Center, Amsterdam, Netherlands )

European Cancer Organisation: Time To Act

Professor Mark Lawler - Queens University Belfast, Belfast, UK

European Cancer Organisation: Time To Act ( Professor Mark Lawler - Queens University Belfast, Belfast, UK )

Special Issue: Women’s cancer care in fragile, conflict-impacted ecosystems

Special issue authors and funders

Special Issue: Women’s cancer care in fragile, conflict-impacted ecosystems ( Special issue authors and funders )

Women's cancers in the Democratic Republic of Congo

Prof Richard Sullivan - Kings College London, London, UK

Women's cancers in the Democratic Republic of Congo ( Prof Richard Sullivan - Kings College London, London, UK )

Rare inherited pathogenic germline variants observed in sporadic paediatric...

Dr Emily Blauel - Children’s Hospital of Philadelphia, Philadelphia, USA

Rare inherited pathogenic germline variants observed in sporadic paediatric neuroblastoma cases ( Dr Emily Blauel - Children’s Hospital of Philadelphia, Philadelphia, USA )

Psycho-oncology service provisions for hospitalised cancer patients before and...

Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India

Psycho-oncology service provisions for hospitalised cancer patients before and during the COVID19 pandemic ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )

OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

UpSwinG: Real-world, non-interventional cohort study on TKI activity in...

Dr Satoru Miura - Niigata Cancer Center Hospital, Niigata, Japan

UpSwinG: Real-world, non-interventional cohort study on TKI activity in patients with EGFRm NSCLC with uncommon mutations ( Dr Satoru Miura - Niigata Cancer Center Hospital, Niigata, Japan )

PIPSeN trial: Olaparib maintenance vs placebo in platinum-sensitive non-small...

Dr Sophie Postel-Vinay - Gustave Roussey Cancer Center, Paris, France

PIPSeN trial: Olaparib maintenance vs placebo in platinum-sensitive non-small cell lung cancer ( Dr Sophie Postel-Vinay - Gustave Roussey Cancer Center, Paris, France )

Efficacy and early discontinuation predictors in NSCLC patients receiving...

Dr Giulia Pasello - University of Padova, Padua, Italy

Efficacy and early discontinuation predictors in NSCLC patients receiving nivolumab ( Dr Giulia Pasello - University of Padova, Padua, Italy )

More from ecancer